Ovagen (20 mg Vial) Dosage Protocol
Ovagen (Glu-Asp-Leu) is a synthetic tripeptide bioregulator targeting hepatocytes, studied in Russian protocols for liver support, hepatic regeneration, and detoxification pathways.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (2 mL = 10 mg/mL)
| Week | Daily Dose (μg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 10 μg (0.01 mg) | 0.1 units (0.001 mL) |
| Weeks 3–4 | 20 μg (0.02 mg) | 0.2 units (0.002 mL) |
| Weeks 5–6 | 50 μg (0.05 mg) | 0.5 units (0.005 mL) |
| Weeks 7–8 | 100 μg (0.1 mg) | 1 unit (0.01 mL) |
| Weeks 9–16 | 100–150 μg (0.1–0.15 mg) | 1–1.5 units (0.01–0.015 mL) |
Frequency: Inject once daily subcutaneously. Because all per-administration volumes are ≤1.5 units (≤0.015 mL), use 30-unit or 50-unit insulin syringes for improved readability and accuracy. Titrate slowly by adding 10–20 μg (0.1–0.2 units) every 1–2 weeks as tolerated.
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on a 16-week daily protocol with gradual titration. One 20 mg vial provides approximately 13,510 μg total usage over 16 weeks, so a single vial is sufficient for the full course.
| Item | Quantity |
|---|---|
| Peptide Vials (Ovagen, 20 mg each) | 16 weeks: 1 vial (with excess remaining) |
| Insulin Syringes (U-100, 30-unit or 50-unit recommended) | Per week: 7 syringes (1/day) 16 weeks: 112 syringes (recommend ~120 with extras) |
| Bacteriostatic Water (10 mL bottles) | 16 weeks (1 vial): 2 mL → 1 × 10 mL bottle |
| Alcohol Swabs | Per week: 14 swabs (2/day) 16 weeks: 224 swabs → recommend 3 × 100-count boxes |
Protocol Overview
The hypothesized gene-expression mechanism produces effects that persist months after the cycle ends, supporting the cycled rather than continuous approach. Evidence base is primarily Russian gerontology and clinical research; peer-reviewed Western data is limited.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 30 days, protect from light |
Important Notes
How This Works
Ovagen is a Khavinson-class peptide bioregulator hypothesized to support hepatocyte gene expression and detoxification enzyme activity in the liver.
Potential Benefits & Side Effects
Potential Benefits
- Hepatoprotective support in Russian clinical protocols.
- Studied for post-viral hepatitis recovery.
- May support detoxification pathways.
Side Effect Profile
- Generally well-tolerated in Russian clinical literature.
- Mild injection-site reactions.
- Limited peer-reviewed Western data.
Lifestyle Factors
- Adequate sleep and rest during cycles.
- Balanced nutrition supports cellular repair.
Injection Technique
- Subcutaneous, rotate sites daily during 20-day cycle.